Try our beta test site
152 studies found for:    "myoclonic epilepsy myopathy sensory ataxia" OR "Mitochondrial Diseases"
Show Display Options
Rank Status Study
1 Terminated Anesthetic Effects in Mitochondrial Disease
Condition: Mitochondrial Disease
Intervention: Drug: sevoflurane
2 Completed Glycemic Index in Mitochondrial Disease
Condition: Mitochondrial Diseases
Intervention: Other: test meal
3 Recruiting Anesthesia in Patients With Mitochondrial Disease
Condition: Mitochondrial Diseases
Interventions: Drug: Sevoflurane;   Drug: Dexmedetomidine;   Drug: Propofol
4 Recruiting Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
Condition: Mitochondrial Disease
Intervention:
5 Completed
Has Results
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
Condition: Mitochondrial Diseases
Interventions: Drug: CoenzymeQ10;   Drug: Placebo
6 Enrolling by invitation Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Disease (PMD)
Condition: Primary Mitochondrial Disease
Intervention: Drug: elamipretide
7 Completed Survey on Supplement Use in Mitochondrial Disease
Condition: Mitochondrial Disease
Intervention:
8 Active, not recruiting Calf Muscle Strength in Mitochondrial Diseases
Condition: Mitochondrial Disease
Intervention: Other: MRI and muscle dynamometer
9 Active, not recruiting A Long-Term Extension Study of RP103-MITO-001 (NCT02023866) to Assess RP103 in Children With Inherited Mitochondrial Disease
Condition: Mitochondrial Diseases
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules
10 Recruiting The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases
Condition: Mitochondrial Diseases
Interventions: Dietary Supplement: Arginine;   Dietary Supplement: Citrulline
11 Terminated RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
Condition: Mitochondrial Diseases
Intervention: Drug: RG2133 (2',3',5'-tri-O-acetyluridine)
12 Recruiting An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)
Condition: Primary Mitochondrial Disease
Intervention:
13 Active, not recruiting A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study
Condition: Primary Mitochondrial Disease
Interventions: Drug: Elamipretide;   Drug: Placebo
14 Completed Energy Requirements in Mitochondrial Disease
Conditions: Mitochondrial Disease;   Chronic Metabolic Disorder
Intervention:
15 Enrolling by invitation DINAMITE Study Nutritional State and Effect Diet in Mitochondrial Disease
Condition: Mitochondrial Disorders
Intervention: Behavioral: diet intervention
16 Completed Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease
Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention: Drug: Cysteamine Bitartrate
17 Recruiting GDF-15 as a Biomarker for Mitochondrial Disease
Conditions: Mitochondrial Disease;   Metabolic Myopathy;   Muscular Dystrophy
Intervention:
18 Completed Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders
Conditions: Gastrointestinal Dysfunction;   Mitochondrial Disorders
Intervention: Procedure: gastric emptying scan
19 Recruiting North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Conditions: Mitochondrial Disorders;   Mitochondrial Genetic Disorders;   Mitochondrial Diseases;   Disorder of Mitochondrial Respiratory Chain Complexes;   Deletion and Duplication of Mitochondrial DNA
Intervention:
20 Active, not recruiting EPI-743 for Mitochondrial Respiratory Chain Diseases
Condition: Mitochondrial Diseases
Intervention: Drug: EPI-743

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.